No Child Left Behind

Liver Transplantation in Critically Ill Children

Abbas Rana, Michael Kueht, Moreshwar Desai, Fong Lam, Tamir Miloh, Jennifer Moffett, N. Thao N. Galvan, Ronald Cotton, Christine O'Mahony, John Goss

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Advances in critical care prolong survival in children with liver failure, allowing more critically ill children to undergo orthotopic liver transplantation (OLT). In order to justify the use of a scarce donor resource and avoid futile transplants, we sought to determine survival in children who undergo OLT while receiving pre-OLT critical care. Study Design We analyzed 13,723 pediatric OLTs using the United Network for Organ Sharing (UNOS) database from 1987 to 2015, including 6,746 recipients in the Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease (MELD/PELD) era (2002 to 2015). There were 1,816 recipients (26.9%) admitted to the ICU at the time of transplantation. We also analyzed 354 pediatric OLT recipients at our center from 2002 to 2015, one of the largest institutional experiences. Sixty-five recipients (18.3%) were admitted to the ICU at the time of transplantation. Kaplan-Meier, volume threshold, and multivariable analyses were performed. Results Patient survival improved steadily over the study period, (66% 1-year survival in 1987 vs 92% in 2015; p < 0.001). Our institutional experience of ICU recipients in the MELD/PELD era had acceptable outcomes (87% 1-year survival), even among our sickest recipients with vasoactive medications, mechanical ventilation, dialysis, and molecular adsorbent recirculating system requirements. Volume analysis revealed inferior outcomes (hazard ratio [HR] 1.68; 95% CI 1.11 to 2.51) in low-volume centers (<5 annual cases). Identifiable risk factors (previous transplantation, elevated serum sodium, hemodialysis, mechanical ventilation, body weight < 6 kg, and low center volume) increased risk of mortality. Conclusions This analysis demonstrates that the use of advanced critical care in children and infants with liver failure is justified because OLT can be performed on the sickest children and acceptable outcomes achieved. It is an appropriate use of a scarce donor allograft in a child who would otherwise succumb to a terminal liver disease.

Original languageEnglish (US)
Pages (from-to)671-677
Number of pages7
JournalJournal of the American College of Surgeons
Volume224
Issue number4
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Critical Illness
Liver Transplantation
End Stage Liver Disease
Critical Care
Survival
Pediatrics
Transplantation
Liver Failure
Artificial Respiration
Tissue Donors
Allografts
Renal Dialysis
Liver Diseases
Dialysis
Sodium
Body Weight
Databases
Transplants
Mortality
Serum

ASJC Scopus subject areas

  • Surgery

Cite this

No Child Left Behind : Liver Transplantation in Critically Ill Children. / Rana, Abbas; Kueht, Michael; Desai, Moreshwar; Lam, Fong; Miloh, Tamir; Moffett, Jennifer; Galvan, N. Thao N.; Cotton, Ronald; O'Mahony, Christine; Goss, John.

In: Journal of the American College of Surgeons, Vol. 224, No. 4, 01.04.2017, p. 671-677.

Research output: Contribution to journalArticle

Rana, A, Kueht, M, Desai, M, Lam, F, Miloh, T, Moffett, J, Galvan, NTN, Cotton, R, O'Mahony, C & Goss, J 2017, 'No Child Left Behind: Liver Transplantation in Critically Ill Children', Journal of the American College of Surgeons, vol. 224, no. 4, pp. 671-677. https://doi.org/10.1016/j.jamcollsurg.2016.12.025
Rana, Abbas ; Kueht, Michael ; Desai, Moreshwar ; Lam, Fong ; Miloh, Tamir ; Moffett, Jennifer ; Galvan, N. Thao N. ; Cotton, Ronald ; O'Mahony, Christine ; Goss, John. / No Child Left Behind : Liver Transplantation in Critically Ill Children. In: Journal of the American College of Surgeons. 2017 ; Vol. 224, No. 4. pp. 671-677.
@article{0380006822a542798359da3bb0ece346,
title = "No Child Left Behind: Liver Transplantation in Critically Ill Children",
abstract = "Background Advances in critical care prolong survival in children with liver failure, allowing more critically ill children to undergo orthotopic liver transplantation (OLT). In order to justify the use of a scarce donor resource and avoid futile transplants, we sought to determine survival in children who undergo OLT while receiving pre-OLT critical care. Study Design We analyzed 13,723 pediatric OLTs using the United Network for Organ Sharing (UNOS) database from 1987 to 2015, including 6,746 recipients in the Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease (MELD/PELD) era (2002 to 2015). There were 1,816 recipients (26.9{\%}) admitted to the ICU at the time of transplantation. We also analyzed 354 pediatric OLT recipients at our center from 2002 to 2015, one of the largest institutional experiences. Sixty-five recipients (18.3{\%}) were admitted to the ICU at the time of transplantation. Kaplan-Meier, volume threshold, and multivariable analyses were performed. Results Patient survival improved steadily over the study period, (66{\%} 1-year survival in 1987 vs 92{\%} in 2015; p < 0.001). Our institutional experience of ICU recipients in the MELD/PELD era had acceptable outcomes (87{\%} 1-year survival), even among our sickest recipients with vasoactive medications, mechanical ventilation, dialysis, and molecular adsorbent recirculating system requirements. Volume analysis revealed inferior outcomes (hazard ratio [HR] 1.68; 95{\%} CI 1.11 to 2.51) in low-volume centers (<5 annual cases). Identifiable risk factors (previous transplantation, elevated serum sodium, hemodialysis, mechanical ventilation, body weight < 6 kg, and low center volume) increased risk of mortality. Conclusions This analysis demonstrates that the use of advanced critical care in children and infants with liver failure is justified because OLT can be performed on the sickest children and acceptable outcomes achieved. It is an appropriate use of a scarce donor allograft in a child who would otherwise succumb to a terminal liver disease.",
author = "Abbas Rana and Michael Kueht and Moreshwar Desai and Fong Lam and Tamir Miloh and Jennifer Moffett and Galvan, {N. Thao N.} and Ronald Cotton and Christine O'Mahony and John Goss",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.jamcollsurg.2016.12.025",
language = "English (US)",
volume = "224",
pages = "671--677",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - No Child Left Behind

T2 - Liver Transplantation in Critically Ill Children

AU - Rana, Abbas

AU - Kueht, Michael

AU - Desai, Moreshwar

AU - Lam, Fong

AU - Miloh, Tamir

AU - Moffett, Jennifer

AU - Galvan, N. Thao N.

AU - Cotton, Ronald

AU - O'Mahony, Christine

AU - Goss, John

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background Advances in critical care prolong survival in children with liver failure, allowing more critically ill children to undergo orthotopic liver transplantation (OLT). In order to justify the use of a scarce donor resource and avoid futile transplants, we sought to determine survival in children who undergo OLT while receiving pre-OLT critical care. Study Design We analyzed 13,723 pediatric OLTs using the United Network for Organ Sharing (UNOS) database from 1987 to 2015, including 6,746 recipients in the Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease (MELD/PELD) era (2002 to 2015). There were 1,816 recipients (26.9%) admitted to the ICU at the time of transplantation. We also analyzed 354 pediatric OLT recipients at our center from 2002 to 2015, one of the largest institutional experiences. Sixty-five recipients (18.3%) were admitted to the ICU at the time of transplantation. Kaplan-Meier, volume threshold, and multivariable analyses were performed. Results Patient survival improved steadily over the study period, (66% 1-year survival in 1987 vs 92% in 2015; p < 0.001). Our institutional experience of ICU recipients in the MELD/PELD era had acceptable outcomes (87% 1-year survival), even among our sickest recipients with vasoactive medications, mechanical ventilation, dialysis, and molecular adsorbent recirculating system requirements. Volume analysis revealed inferior outcomes (hazard ratio [HR] 1.68; 95% CI 1.11 to 2.51) in low-volume centers (<5 annual cases). Identifiable risk factors (previous transplantation, elevated serum sodium, hemodialysis, mechanical ventilation, body weight < 6 kg, and low center volume) increased risk of mortality. Conclusions This analysis demonstrates that the use of advanced critical care in children and infants with liver failure is justified because OLT can be performed on the sickest children and acceptable outcomes achieved. It is an appropriate use of a scarce donor allograft in a child who would otherwise succumb to a terminal liver disease.

AB - Background Advances in critical care prolong survival in children with liver failure, allowing more critically ill children to undergo orthotopic liver transplantation (OLT). In order to justify the use of a scarce donor resource and avoid futile transplants, we sought to determine survival in children who undergo OLT while receiving pre-OLT critical care. Study Design We analyzed 13,723 pediatric OLTs using the United Network for Organ Sharing (UNOS) database from 1987 to 2015, including 6,746 recipients in the Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease (MELD/PELD) era (2002 to 2015). There were 1,816 recipients (26.9%) admitted to the ICU at the time of transplantation. We also analyzed 354 pediatric OLT recipients at our center from 2002 to 2015, one of the largest institutional experiences. Sixty-five recipients (18.3%) were admitted to the ICU at the time of transplantation. Kaplan-Meier, volume threshold, and multivariable analyses were performed. Results Patient survival improved steadily over the study period, (66% 1-year survival in 1987 vs 92% in 2015; p < 0.001). Our institutional experience of ICU recipients in the MELD/PELD era had acceptable outcomes (87% 1-year survival), even among our sickest recipients with vasoactive medications, mechanical ventilation, dialysis, and molecular adsorbent recirculating system requirements. Volume analysis revealed inferior outcomes (hazard ratio [HR] 1.68; 95% CI 1.11 to 2.51) in low-volume centers (<5 annual cases). Identifiable risk factors (previous transplantation, elevated serum sodium, hemodialysis, mechanical ventilation, body weight < 6 kg, and low center volume) increased risk of mortality. Conclusions This analysis demonstrates that the use of advanced critical care in children and infants with liver failure is justified because OLT can be performed on the sickest children and acceptable outcomes achieved. It is an appropriate use of a scarce donor allograft in a child who would otherwise succumb to a terminal liver disease.

UR - http://www.scopus.com/inward/record.url?scp=85012909906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012909906&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2016.12.025

DO - 10.1016/j.jamcollsurg.2016.12.025

M3 - Article

VL - 224

SP - 671

EP - 677

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 4

ER -